A well‐tolerated grass pollen‐specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
Top Cited Papers
- 1 June 2001
- Vol. 56 (6) , 498-505
- https://doi.org/10.1034/j.1398-9995.2001.056006498.x
Abstract
Background: We present data showing that a Th1‐inducing adjuvant can reduce the number of injections required for allergy vaccination. Allergy vaccination is the only treatment for type 1 hypersensi...Keywords
This publication has 22 references indexed in Scilit:
- Mechanisms of allergen‐specific immunotherapyAllergy, 2000
- Reducing IgE levels as a strategy for the treatment of asthmaClinical and Experimental Allergy, 2000
- Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administrationVaccine, 2000
- Delivery of MUC1 Mucin Peptide by Poly(d,l-lactic-co-Glycolic Acid) Microspheres Induces type 1T Helper Immune ResponsesJournal of Pharmaceutical Sciences, 1998
- Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in LiposomesThe Journal of Infectious Diseases, 1996
- Basophil Histamine Release and Humoral Changes during ImmunotherapyAllergy, 1982
- L-Tyrosine as an Immunological AdjuvantInternational Archives of Allergy and Immunology, 1982
- Chemical Modification of Crude Timothy Grass Pollen ExtractInternational Archives of Allergy and Immunology, 1977
- Chemical Modification of Crude Timothy Grass Pollen ExtractInternational Archives of Allergy and Immunology, 1976
- Glutaraldehyde‐pollen‐tyrosine: clinical and immunological studiesClinical and Experimental Allergy, 1974